ArticleMolecular therapy. Oncology2026

Nanobody-engineered CLL-1 CAR T cells: A strategy for safer targeting in acute myeloid leukemia.

Chakrapani Tripathi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.